Less Ads, More Data, More Tools Register for FREE

Pin to quick picksApax Global Alpha Regulatory News (APAX)

  • This share is currently suspended. It was suspended at a price of 164.40
  • There is currently no data for APAX

Further irrevocable undertakings

29 Jul 2025 07:00

RNS Number : 8875S
Apax Partners LLP
29 July 2025
Ā 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION.

THIS IS A DISCLOSURE UNDER RULE 2.10(a) OF THE CITY CODE ON TAKEOVERS AND MERGERS (THE "CODE").

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION.

FOR IMMEDIATE RELEASE

29 July 2025

Recommended Offer for Apax Global Alpha Limited ("AGA")

Further irrevocable undertakings given by AGA shareholders

DISCLOSURE UNDER RULE 2.10(a) OF THE CODE

On 21 July 2025, the boards of Janus Bidco Limited ("Bidco"), a newly-formed Guernsey limited company indirectly owned by an investment vehicle to be advised by Apax Partners LLP ("Apax"), and AGA announced that they had agreed the terms of a recommended cash acquisition of the entire issued and to be issued ordinary share capital of AGA by Bidco (the "Acquisition"), to be effected by means of a court-sanctioned scheme of arrangement under Part VIII of the Companies (Guernsey) Law, 2008, as amended (the "Scheme"). This was announced via an announcement of Bidco's intention to make a firm offer under Rule 2.7 of the Code ("Rule 2.7 Announcement").

Capitalised terms used in this announcement which are not otherwise defined have the meaning given to them in the Rule 2.7 Announcement.

The Rule 2.7 Announcement noted that Bidco had received:

Ā· irrevocable undertakings from each of the AGA Directors who hold AGA Shares to: (i) vote or procure votes in favour of the Scheme at the Court Meeting and the Resolutions at the General Meeting (or, in the event that the Acquisition is implemented by way of a Takeover Offer, to accept or procure acceptance of such Takeover Offer); and (ii) receive the Cash Consideration, in each case, in respect of all of the Scheme Shares of which they are the registered or beneficial holder;

Ā· irrevocable undertakings from certain AGA Shareholders to vote or procure votes in favour of the Scheme at the Court Meeting and the Resolutions at the General Meeting (or, in the event that the Acquisition is implemented by way of a Takeover Offer, to accept or procure acceptance of such Takeover Offer), in each case, in respect of all of the Scheme Shares of which they are the registered or beneficial holder; and

Ā· letters of intent to vote or procure votes in favour of the Scheme at the Court Meeting and the Resolutions at the General Meeting (or, in the event that the Acquisition is implemented by way of a Takeover Offer, to accept or procure acceptance of such Takeover Offer), in each case, in respect of all of the Scheme Shares of which they are the registered or beneficial holder,

(together, the "Prior Irrevocables and LOIs").

Bidco has now received further irrevocable undertakings to: (i) vote or procure votes in favour of the Scheme at the Court Meeting and the Resolutions at the General Meeting (or, in the event that the Acquisition is implemented by way of a Takeover Offer, to accept or procure acceptance of such Takeover Offer); and (ii) elect to accept, and otherwise take all steps necessary to give such election to accept, the Alternative Offer, in each case, in respect of all of the Scheme Shares of which they are the registered or beneficial holder, from the AGA Shareholders set out in the table below (together, the "New Irrevocables"):

Name

Number of AGA Shares in respect of which undertaking is given

Percentage of AGA's issued share capital in respect of which undertaking is given

Adam Garson

5,236

0.00%

Anders Meyerhoff

18,000

0.00%

Arthur Brothag

250,321

0.05%

Ashish Karandikar & Magdalena Jurkiewicz

1,043,890

0.22%

Frank Ehmer

1,890,885

0.39%

Gabriele Cipparrone

1,185,513

0.25%

Harjot Dhaliwal

35,202

0.01%

Jason Wright

3,977,781

0.82%

Marcelo Gigliani

72,541

0.02%

Mark Zubko

100,512

0.02%

Anne H Zubko Trust

200,000

0.04%

Chinedum Ottih

32,693

0.01%

Nicholas Alan Hartman

143,024

0.03%

Richard Zhang

4,026,843

0.83%

Rohan Haldea

1,193,326

0.25%

Roxana Mirica

73,025

0.02%

Roy Mackenzie

1,680,628

0.35%

Seth Brody

832,845

0.17%

Simon Cresswell

34,304

0.01%

Steven Kooyers

101,392

0.02%

Zehavit Cohen

16,609

0.00%

Yuli Yardeni

242,594

0.05%

Total:

17,157,164

3.56%

Ā 

The New Irrevocables relate to 17,157,164 AGA Shares in aggregate, representing approximately 3.56 per cent. of the issued share capital of AGA as at 28 July 2025 (being the last business day prior to the date of this announcement).

In total, therefore, Bidco has received irrevocable undertakings and letters of intent to vote or procure votes in favour of the Scheme at the Courting Meeting and the Resolutions at the General Meeting (or, in the event that the Acquisition is implemented by way of a Takeover Offer, to accept or procure acceptance of such Takeover Offer) in respect of, in aggregate, 185,374,838 AGA Shares, representing 38.43 per cent. of the issue shared capital of AGA as at close of business on 28 July 2025 (being the last business day prior to the date of this announcement).

Bidco has now received irrevocable undertakings to elect for the Alternative Offer, in respect of, in aggregate, 49,850,175 AGA Shares, representing approximately 10.13 per cent. of the AGA Shares in issue as at close of business on 28 July 2025 (being the last business day prior to the date of this announcement).

In accordance with Rule 26.1 of the Code, a copy of this announcement and of each of the New Irrevocables will be available, subject to certain restrictions relating to persons resident in certain jurisdictions, at https://www.apaxglobalalpha.com/investor-centre/offer promptly and by no later than 12 noon (London time) on the business day following the date of this announcement.Ā The content of this website is not incorporated in, and does not form part of, this announcement.

Enquiries:

Apax / Bidco

Katarina Sallerfors

+44 (0) 207 872 6300

J.P. Morgan Cazenove (Sole Financial Adviser to Bidco (indirectly owned by an investment vehicle to be advised by Apax Partners LLP))

James Robinson

JƩrƩmie Birnbaum

Valentina Proverbio

+44 (0) 203 493 8000

Campbell Lutyens & Co. Ltd (Secondary Adviser to Bidco (indirectly owned by an investment vehicle to be advised by Apax Partners LLP))

Immanuel Rubin

Ana Dicu

Ryan Franklin

+44 (0) 20 7439 7191

FTI Consulting (Communications Adviser to Apax and Bidco)

Alex Le May

Mitch Barltrop

Alexander Davis

+44 (0)20 3727 1000

ApaxPartners@fticonsulting.com

Additional information

This announcement is not intended to, and does not, constitute or form part of any offer, invitation or solicitation of any offer to purchase, otherwise acquire, subscribe for, sell or otherwise dispose of, any securities or the solicitation of any vote or approval in any jurisdiction, whether pursuant to this announcement or otherwise. Any offer, if made, will be made solely by certain offer documentation which will contain the full terms and conditions of any offer, including details of how it may be accepted.

The release, distribution or publication of this announcement in jurisdictions outside the United Kingdom may be restricted by laws of the relevant jurisdictions and therefore persons into whose possession this announcement comes should inform themselves about, and observe, any such restrictions. Any failure to comply with the restrictions may constitute a violation of the securities law of any such jurisdiction.

In accordance with Rule 2.4(c)(iii) of the Code, Bidco confirms that it is not aware of any dealings in AGA Shares that would require a minimum level, or particular form, of consideration that it would be obliged to offer under Rule 6 or Rule 11 of the Code (as appropriate). However, it has not been practicable for Bidco to make enquiries of all persons presumed to be acting in concert with it prior to this announcement in order to confirm whether any details are required to be disclosed under Rule 2.4(c)(iii). To the extent that any such details are identified following such enquiries, Bidco will make an announcement disclosing such details as soon as practicable, and in any event by no later than the time it is required to make its Opening Position Disclosure under Rule 8.1 of the Code.

Disclaimer

J.P. Morgan Securities plc, which conducts its UK investment banking business as J.P. Morgan Cazenove ("J.P. Morgan Cazenove"), is authorised in the United Kingdom by the PRA and regulated in the United Kingdom by the PRA and the FCA. J.P. Morgan Cazenove is acting as financial adviser exclusively for Bidco and no one else in connection with the matters set out in this Announcement and will not regard any other person as its client in relation to the matters in this announcement and will not be responsible to anyone other than Apax and Bidco for providing the protections afforded to clients of J.P. Morgan Cazenove or its affiliates, nor for providing advice in relation to any matter referred to herein.

Rounding

Certain figures included in this announcement have been subjected to rounding adjustments.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Ā 
END
Ā 
Ā 
OUPRPMLTMTITBRA
Date   Source Headline
7th May 20247:00 amRNSApax IX agrees to sell Healthium
2nd May 20247:00 amRNSAudit Committee Change
2nd May 20247:00 amRNSResult of AGM
2nd May 20247:00 amRNSQuarterly Results to 31 March 2024
24th Apr 20247:00 amRNSApax Funds to acquire IANS
18th Apr 20247:00 amRNSApax Funds To Acquire Zellis Group
5th Apr 20249:58 amRNSDirector/PDMR Shareholding
4th Apr 20242:02 pmRNSDirector/PDMR Shareholding
27th Mar 20247:00 amRNSNotice of Capital Markets Day
22nd Mar 202410:08 amRNSHolding in Company
11th Mar 20245:17 pmRNSPurchase of Ordinary Shares under IMA
5th Mar 20247:00 amRNS2023 Annual Dividend Declaration
5th Mar 20247:00 amRNSNotice of AGM
5th Mar 20247:00 amRNS2023 Annual Report and Accounts
5th Mar 20247:00 amRNS2023 Final Results
1st Mar 20242:00 pmRNSRetirement of Chris Ambler from the Board
28th Feb 20247:00 amRNSApax Funds Acquire IES
8th Feb 20247:00 amRNSEstimated Adjusted NAV as at 31 December 2023
2nd Feb 20247:00 amRNSApax Funds Acquire WGSN
4th Dec 20233:00 pmEQSHardman & Co Q&A on Apax Global Alpha: Hidden gems strategy delivering new investment opportunities
23rd Nov 202312:43 pmEQSHardman & Co Research on Apax Global Alpha (APAX): “Hidden Gems” strategy: green shoots into live deals
17th Nov 202312:58 pmRNSDirector/PDMR Shareholding
15th Nov 20237:00 amRNSApax Funds Invest in Petvisor
9th Nov 20237:00 amRNSQuarterly Results to 30 September 2023
27th Oct 20237:00 amRNSApax Funds Acquire GAN Integrity
12th Oct 20232:15 pmEQSHardman & Co Q&A on Apax Global Alpha (APAX): Confirming strong underlying competitive advantages
11th Oct 20237:00 amRNSApax Funds acquire Bazooka Candy Brands
5th Oct 20237:00 amRNSNotice of Q3 2023 Financial Results
2nd Oct 20237:00 amRNSDirectorate Change
25th Sep 20235:06 pmRNSHolding in Company
25th Sep 20232:45 pmEQSHardman & Co Research on Apax Global Alpha (APAX): Resilience in face of rising interest rates
12th Sep 202311:30 amRNSDirector/PDMR Shareholding
6th Sep 20237:02 amRNS2023 Interim Dividend
6th Sep 20237:01 amRNS2023 Interim Report and Accounts
6th Sep 20237:00 amRNS2023 Interim Results Highlights
7th Aug 20237:00 amRNSEstimated Adjusted NAV as at 30 June 2023
1st Aug 20237:00 amRNSFunds advised by Apax to acquire Palex
20th Jul 20234:35 pmEQSHardman & Co Q&A on Apax Global Alpha (APAX) Capital Markets Day: value added by the manager
5th Jul 20233:50 pmEQSHardman & Co Research on Apax Global Alpha (APAX) 2023 Capital Markets Day: accessing hidden gems
2nd Jun 20237:00 amRNSFunds advised by Apax invest in Swing Education
23rd May 20237:00 amRNSNotice of Capital Markets Day
16th May 20237:00 amRNSFunds advised by Apax to acquire IBS Software
4th May 20237:00 amRNSResult of AGM
4th May 20237:00 amRNSQuarterly results for 31 March 2023
21st Mar 20232:05 pmEQSHardman & Co Q&A on Apax Global Alpha (APAX): 2022 results adding value to companies leads to outperformance
14th Mar 20232:05 pmEQSHardman & Co Research on Apax Global Alpha (APAX): Outperformance by adding value to companies
13th Mar 20237:00 amRNSUpdate relating to SVB
2nd Mar 20237:00 amRNS2022 Annual Dividend Declaration
2nd Mar 20237:00 amRNSNotice of AGM
2nd Mar 20237:00 amRNS2022 Annual Report and Accounts

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.